Owlet, Inc.
General ticker "OWLT" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $2.0B (TTM average)
Owlet, Inc. does not follow the US Stock Market performance with the rate: -15.6%.
Estimated limits based on current volatility of 2.6%: low 4.28$, high 4.52$
Factors to consider:
- Total employees count: 114 (+34.1%) as of 2025
- US accounted for 81.8% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: History of losses, Failure to achieve profitability, Capital raising, Funding failure, Strategic risks and growth management
- Current price 49.3% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [8.10$, 20.02$]
- 2026-12-31 to 2027-12-31 estimated range: [5.75$, 14.94$]
Financial Metrics affecting the OWLT estimates:
- Positive: with PPE of -32.1 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Net income
- Positive: -13.52 < Operating profit margin, % of -7.25
- Negative: negative Industry operating cash flow (median)
- Negative: Investing cash flow per share per price, % of -0.33 <= -0.14
- Negative: -1.30 < Inventory ratio change, % of -0.93
- Negative: 12.78 < Shareholder equity ratio, % of 22.24 <= 25.20
- Positive: Industry inventory ratio change (median), % of 0.70 <= 1.15
- Negative: Industry earnings per price (median), % of -3.46 <= 0
Short-term OWLT quotes
Long-term OWLT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $54.01MM | $78.06MM | $105.71MM |
| Operating Expenses | $82.64MM | $98.28MM | $113.97MM |
| Operating Income | $-28.63MM | $-20.22MM | $-8.26MM |
| Non-Operating Income | $-4.26MM | $7.74MM | $-31.39MM |
| Interest Expense | $3.19MM | $1.63MM | $3.42MM |
| R&D Expense | $10.35MM | $9.80MM | $14.08MM |
| Income(Loss) | $-32.89MM | $-12.48MM | $-39.65MM |
| Taxes | $0.01MM | $0.05MM | $0.03MM |
| Net Income(Loss)* | $-32.90MM | $-12.54MM | $-39.68MM |
| Stockholders Equity | $-37.53MM | $-29.75MM | $19.04MM |
| Inventory | $6.49MM | $10.52MM | $15.30MM |
| Assets | $44.12MM | $49.52MM | $85.63MM |
| Operating Cash Flow | $-23.53MM | $-11.21MM | $-10.79MM |
| Capital expenditure | $0.06MM | $0.76MM | $0.27MM |
| Investing Cash Flow | $-0.06MM | $-0.76MM | $-0.94MM |
| Financing Cash Flow | $28.91MM | $16.04MM | $32.12MM |
| Earnings Per Share** | $-3.98 | $-1.13 | $-2.13 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.